Search Results - "Baka, O."

Effect of Al concentrations on the electrodeposition and properties of transparent Al-doped ZnO thin films by Baka, O., Azizi, A., Velumani, S., Schmerber, G., Dinia, A.

“…Al-doped zinc oxide (AZO) thin films are prepared on polycrystalline fluorine-doped tin oxide-coated conducting glass substrates from nitrates baths by the…”
Get full text

New Approaches to the Diagnosis and the Symptomatic Treatment of Hepatic Encephalopathy by Manzhalii, E, Kondratiuk, V, Scherbinina, M, Baka, O

Get full text

Changing eating behavior by motivational and controlled program during 12 weeks reduce weight, cytokeratin 18 levels and steatosis in patient with NAFLD by Dynnyk, N, Svintsitsky, A, Solovyova, G, Baka, O, Chernyavskyi, V, Yarmenchuk, I, Hvozdetska, L

Get full text

Physical Activity Reduce Hepatic Apoptosis in Patients with Non-Alcoholic Fatty Liver Disease and Visceral Obesity by Dynnyk, N, Svintsitsky, A, Solovyova, G, Bogomaz, V, Baka, O, Gurbych, O, Golovchanska, Y

Get full text

Effect of nitrate concentration on the electrochemical growth and properties of ZnO nanostructures by Mentar, L., Baka, O., Khelladi, M. R., Azizi, A., Velumani, S., Schmerber, G., Dinia, A.

“…Zinc oxide (ZnO) nanostructures were deposited under potentiostatic control on indium tin oxide coated glass substrate from an aqueous solution containing zinc…”
Get full text

Growth and properties of electrodeposited transparent Al-doped ZnO nanostructures by Baka, O., Mentar, L., Khelladi, M. R., Azizi, A.

“…Al-doped zinc oxide (AZO) nanostructures were fabricated on fluorine-doped tin-oxide (FTO)- coated glass substrates by using electrodeposition. The effects of…”
Get full text

Improvement of Diagnostic Algorithm in Patients With Alcoholic Fatty Liver Disease by Using Non-invasive Methods of Verification of Liver Steatosis and Fibrosis by Svintsitskyy, A., Solovyova, G., Dynnyk, N., Bogomaz, V., Baka, O.

“…Introduction. Nonalcoholic fatty liver disease (NAFLD) is considered as one of the most common chronic liver diseases, and among the population of developed…”
Get full text

THU-273 - Features of levels of neurospecific proteins in patients with hepatic encephalopathy by Dynnyk, N., Manzhalii, E., Baka, O., Lysianyi, M.

Get full text

Features of levels of neurospecific proteins in patients with hepatic encephalopathy by Dynnyk, N., Manzhalii, E., Baka, O., Lysianyi, M.

Get full text

Efficacy and safety of postbiotic supplementation in patients with obesity/prediabetes: A randomized clinical trial (DELI_OBES study) by Savytska, M., Baka, O., Manzhalii, E., Kyriienko, D., Falalyeyeva, T., Sichel, L., Kobyliak, N.

Get full text

THU-034 - New Approaches to the Diagnosis and the Symptomatic Treatment of Hepatic Encephalopathy by Manzhalii, E., Kondratiuk, V., Scherbinina, M., Baka, O.

Get full text

FRI-344 - Changing eating behavior by motivational and controlled program during 12 weeks reduce weight, cytokeratin 18 levels and steatosis in patient with NAFLD by Dynnyk, N., Svintsitsky, A., Solovyova, G., Baka, O., Chernyavskyi, V., Yarmenchuk, I., Hvozdetska, L.

Get full text

FRI-319 - Physical Activity Reduce Hepatic Apoptosis in Patients with Non-Alcoholic Fatty Liver Disease and Visceral Obesity by Dynnyk, N., Svintsitsky, A., Solovyova, G., Bogomaz, V., Baka, O., Gurbych, O., Golovchanska, Y.

Get full text

Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases by Cai, Yujia, Bak, Rasmus O, Mikkelsen, Jacob Giehm

“…Future therapeutic use of engineered site-directed nucleases, like zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs),…”
Get full text